Gabriela Ortizomphroy, MD
Family Practice · Aiea, HINPI 1093879884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 651 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among family practice clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 651 payments — averaging $26.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Lilly USA, LLC$2K
- Novo Nordisk$2K
- AstraZeneca$2K
- Boehringer Ingelheim$2K
- AbbVie$1K
- plus $6K from 30 others
What the payments were for
- Food & beverage$17,29599%
- Education$1941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 83 | $2,429 |
| Lilly USA, LLC | 100 | $2,385 |
| Novo Nordisk | 131 | $2,209 |
| AstraZeneca | 51 | $2,042 |
| Boehringer Ingelheim | 47 | $1,567 |
| AbbVie(2 entities) | 39 | $1,156 |
| Bayer | 34 | $1,134 |
| GSK | 25 | $572 |
| Pfizer | 13 | $491 |
| Abbott | 17 | $391 |
| Sanofi-aventis U.S. LLC | 12 | $380 |
| Glaukos Corporation | 4 | $313 |
| Merck | 8 | $256 |
| Exact Sciences | 6 | $234 |
| Novartis | 8 | $187 |
| Eisai Inc. | 5 | $177 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $174 |
| Radius Health, Inc. | 4 | $170 |
| Kowa Pharmaceuticals America, Inc. | 9 | $146 |
| Oyster Point Pharma, Inc. | 6 | $137 |
| Esperion Therapeutics, Inc. | 6 | $136 |
| Insmed, Inc. | 1 | $135 |
| Coloplast | 1 | $128 |
| Arbor Pharmaceuticals, Inc. | 5 | $89 |
| Bausch & Lomb Americas Inc. | 4 | $77 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| Dexcom, Inc. | 1 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $28 |
| Insulet Corporation | 1 | $22 |
| Shire North American Group Inc | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$826
- JARDIANCE$486
- Kerendia$471
- UBRELVY$354
- MOUNJARO$345
- Brinsupri$270
- KRYSTEXXA$260
- Otezla$247
- SOLIQUA 100/33$238
- TRULICITY$218
- iStent infinite Trabecular Micro-Bypass System Model iS3$201
- TEPEZZA$144
- FREESTYLE LIBRE 3$130
- EUCRISA$130
- SenSura Mio$128
- FreeStyle Libre 2$127
- AREXVY$125
- Repatha$125
- CAPVAXIVE$125
- Dayvigo$125
How this compares
$17,489 in reported general payments places this provider in the 95th percentile of 107 family practice providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 148 | $159,551 |
| OzempicSemaglutide | 96 | $149,455 |
| JardianceEmpagliflozin | 119 | $132,591 |
| ProliaDenosumab | 32 | $56,287 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 27 | $28,249 |
| KerendiaFinerenone | 28 | $26,343 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $12,209 |
| Rosuvastatin Calcium | 308 | $10,736 |
| Atorvastatin Calcium | 392 | $9,255 |
| LinzessLinaclotide | 11 | $8,790 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 27 | $7,617 |
| Olmesartan Medoxomil | 117 | $7,185 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 72 | $6,747 |
| Valsartan | 136 | $5,250 |
| Ezetimibe | 127 | $5,250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $1,567 | $160,840146 claims |
| AstraZenecaFarxiga | $2,042 | $159,551148 claims |
| Novo NordiskOzempic | $2,209 | $149,45596 claims |
| AmgenProlia | $2,429 | $56,28732 claims |
| BayerKerendia | $1,134 | $26,34328 claims |
| GSKArexvy, Anoro Ellipta, Breo Ellipta | $572 | $17,47550 claims |
| AbbVieLinzess | $1,156 | $8,79011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 107 family practice providers in Hawaii.
Other family practice in Aiea
- Yupeng LiuAiea$0
- Alvin ValesWaipahu$10K
- Megan Sakamoto-ChunKapolei$0
- Melissa GoslandKamuela$0
- Sachin Gandhi RahmanHilo$0
- Jessica OnoKapolei$0
- Javaid AkhterWailuku$0
- Nina ThalodyHonolulu$0
- Sydney StegallHonolulu$0
- David McCandlessKailua Kona$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.